Niranjan Yanamandra, based in Collegeville, Pennsylvania, United States, is currently a Scientific Director, Biomarkers and Translational Sciences- Immuno-Oncology Combinations at GSK, bringing experience from previous roles at GSK, Arqule and Dyax. Niranjan Yanamandra holds a University of Massachusetts Boston. With a robust skill set that includes Drug Discovery, Molecular Biology, Cell Biology, Assay Development, Biochemistry and more, Niranjan Yanamandra contributes valuable insights to the industry. Niranjan Yanamandra has 3 emails on RocketReach.